Beren Therapeutics P.B.C.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2042
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Oct 16, 2027The maintenance fee for Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same (US 11,958,917) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
Recent changes
- 5 of the patents on this record were granted since Aug 23, 2026
- Nov 3 US 12,780,955 Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
- Nov 3 US 12,780,954 Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
- Nov 3 US 12,779,038 Isomerically Pure Beta-Cyclodextrin Derivatives and Uses Thereof
- Oct 6 US 12,753,248 Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
- Oct 6 US 12,751,966 Methods for the Treatment of Cholesterol Crystal Embolization with Cyclodextrins
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,751,966 | Methods for the Treatment of Cholesterol Crystal Embolization with Cyclodextrins In force · Medium confidence | In force | Medium confidence | |
| US 11,958,917 | Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same In force · High confidence | In force | High confidence | |
| US 12,168,701 | Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same In force · High confidence | In force | High confidence | |
| US 12,215,174 | Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same In force · High confidence | In force | High confidence | |
| US 12,258,426 | Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same In force · Medium confidence | In force | Medium confidence | |
| US 12,509,531 | Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same In force · High confidence | In force | High confidence | |
| US 12,534,542 | Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same In force · High confidence | In force | High confidence | |
| US 12,753,248 | Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same In force · High confidence | In force | High confidence | |
| US 12,779,038 | Isomerically Pure Beta-Cyclodextrin Derivatives and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,780,954 | Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 3 abandoned